After attracting GSK with its subcutaneous delivery tech at the top of the year, South Korea’s Alteogen has snared another Big Pharma partner in Biogen. | Biogen will hand Alteogen $20 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results